[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Adam David Sachs, who serves as President and a director of Vicarious Surgical Inc. (RBOT) and is listed as a 10% owner, acquired a grant of stock options on 06/27/2025. The grant covers 38,675 options with an exercise (conversion) price of $7.61 and an expiration date shown as 06/26/2035. The filing reports the options are held directly by the reporting person following the acquisition.

The award vests in 48 equal monthly installments beginning one month after the grant date, subject to continued service through each vesting date. The Form 4 was signed and dated 08/11/2025 by an attorney-in-fact for the reporting person.

Positive

• Reporting person acquired 38,675 stock options with explicit vesting terms disclosed

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider received 38,675 stock options at a $7.61 strike, vesting monthly over four years; filing shows direct beneficial ownership.

The Form 4 documents an option grant recorded as an acquisition (transaction code A) on 06/27/2025. The option count of 38,675 and the $7.61 exercise price are explicit; the expiration date is 06/26/2035. Vesting is detailed as 48 equal monthly installments beginning one month after the grant, indicating a time-based retention schedule. The options are reported as directly owned by the reporting person. Without company-level context (total shares outstanding or prior holdings) the market impact is indeterminate from this filing alone.

Corporate Governance Expert

TL;DR: Grant to a senior insider with explicit monthly vesting; filing is routine disclosure under Section 16 showing direct ownership.

The document identifies Adam David Sachs as President, a director and a 10% owner, and discloses the acquisition of 38,675 stock options. The vesting schedule — 48 monthly installments beginning one month after grant — and the direct ownership designation are clearly stated. The Form 4 was executed via attorney-in-fact on 08/11/2025. The disclosure is procedural and aligns with Section 16 reporting requirements; it does not by itself disclose performance-based terms or acceleration triggers.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachs Adam David

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.61	06/27/2025		A		38,675		(1)	06/26/2035	Class A Common Stock	38,675	$0.00	38,675	D

Explanation of Responses:

1. The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.

	/s/ Erin Checka, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Adam David Sachs report on Form 4 for RBOT?

He reported acquisition of 38,675 stock options (transaction code A) on 06/27/2025, held directly following the transaction.

What is the exercise price and expiration for the options reported by RBOT insider?

The exercise (conversion) price is $7.61 and the expiration date shown is 06/26/2035.

How do the reported options vest for the RBOT filing?

The options vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to continued service.

What is Adam Sachs's relationship to Vicarious Surgical (RBOT)?

He is listed as President, a director, and a 10% owner of the issuer in the Form 4.

When was the Form 4 signed and filed for the reported RBOT transaction?

The signature by attorney-in-fact is dated 08/11/2025; the transaction date reported is 06/27/2025.